NVIDIA diffusion language model Nemotron TwoTower achieves 2.42x LLM inference throughput without a full retraining run, ...

Goodhart's Law ("When a measure becomes a target, it ceases to be a good measure.") has been around long enough that it ...

Un-0 is an image-generation model built on Kuramoto dynamics: it generates an image by integrating the phase dynamics of a population of coupled oscillators — no diffusion schedule, no adversary, no ...

Netris provides software that runs on network switches, and offers a platform that helps neocloud operators reduce the time ...

TOKYO, JAPAN - FEBRUARY 3: Open AI CEO Sam Altman speaks during a talk session with SoftBank Group CEO Masayoshi Son at an event titled "Transforming Business through AI" in Tokyo, Japan, on February ...

Scientists have created a microscopic QR code so tiny it can only be seen with an electron microscope—smaller than most bacteria and now officially a world record. But this isn’t just about size; it’s ...

OnePlus has begun rolling out a mid-cycle OxygenOS 16.1 update to its devices, with a major focus on refined animations, a redesigned lock-screen experience, and improved AI processing. The update is ...

With the news that Seattle was the proposed location for five large (“hyperscale”) data centers, we were presented with an urgent question: Under what conditions, if any, would this be an acceptable ...

Churchill Downs will be the focus of the sports world on Saturday for the 2026 Kentucky Derby, and new users wanting to bet can claim the exclusive TwinSpires promo code CBSSPORTS to receive up to ...

A giant pit in Switzerland will soon house the world's most powerful redox flow battery In northern Switzerland, a construction team is hard at work excavating a hole in the ground that will end up ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...